middle.news
Inhalerx Taps $247K from $38.5M Facility to Fuel Phase 2 Trials
11:53am on Tuesday 22nd of July, 2025 AEST
•
Healthcare
Read Story
Inhalerx Taps $247K from $38.5M Facility to Fuel Phase 2 Trials
11:53am on Tuesday 22nd of July, 2025 AEST
Key Points
Drawdown of $247,000 from $38.5 million clinical trial funding facility
Positive net cash inflow from operating activities of $489,000
Cash balance of $480,000 at quarter end with $38.2 million unused facility
Facility interest rate set at 15% per annum, capitalised monthly
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
IRX
OPEN ARTICLE